ANITA RAMIREZ: Open Payments
NPI 1871134502 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,512 in 79 payments from 22 companies in 2025. Trend: 2023 $1,265 · 2024 $1,239 · 2025 $1,512
Food & beverage: $1,512
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $325 |
| ABBVIE INC. | 15 | $223 |
| PFIZER INC. | 13 | $217 |
| Lilly USA, LLC | 5 | $93 |
| Intra-Sana Laboratories | 5 | $87 |
| Sumitomo Pharma America, Inc. | 4 | $86 |
| Amgen Inc. | 3 | $74 |
| Exact Sciences Corporation | 3 | $67 |
| Astellas Pharma US Inc | 2 | $57 |
| Novo Nordisk Inc | 2 | $47 |
Products named: NURTEC ODT, AIRSUPRA, UBRELVY, FARXIGA, QULIPTA, RELTONE 200 MG, GEMTESA, Cologuard Collection Kit.
Industry payments across OK — which companies pay providers there.
